| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| gefapixant | p2x purinoceptor 3 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Coughing[MeSHID:D003371] Overactive Bladder[MeSHID:D053201] |
38.19 | phase 3 | antagonist |
| gefapixant | p2x purinoceptor 3 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Coughing[MeSHID:D003371] Overactive Bladder[MeSHID:D053201] |
38.19 | phase 3 | unknown |
| click here to return to the previous page | ||||||||